Lidocaine Pain Relief Gel Patch

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Lidocaine Pain Relief Gel Patch
Generic name
LIDOCAINE PAIN RELIEF
Manufacturer
Dynarex
Product type
HUMAN OTC DRUG
SPL set ID
960e4240-cd09-2560-e053-2a95a90a7bcf
SPL ID
4976f92d-e5db-290c-e063-6294a90afb17
Version
11
Effective date
2026-01-28
Source export date
2026-09-28
Source partition
2
Source file
https://download.open.fda.gov/drug/label/drug-label-0002-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/f7d2b6e3f8600cd856280ab55a9c6fa54a642647191d164f9d1110e89f3f4097/drug-label-0002-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 05:14:58
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For External Use Only Do not use more than 1 patch at a time on wounds or damaged skin with a heating pad if you are allergic to any ingredients of this product When using this product Use only as directed Avoid contact with the eyes, mucous membranes or rashes Do not bandage tightly Single use only Stop use and ask a doctor if Localized skin reactions, such as rash, itching, redness, pain, swelling and blistering develop Conditions worsen Symptoms persist for more than 7 days Symptoms clear up and occur again within a few days if pregnant or breast feeding Ask a health professional before use Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.